home / stock / cybn / cybn short
Short Information | Cybin Inc. (NYSE:CYBN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 4,181,717 |
Total Actual Volume | 124,322,264 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 209,086 |
Average Short Percentage | 3.30% |
Is there a CYBN Short Squeeze or Breakout about to happen?
See the CYBN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $0.2614 | $0.2649 | $0.2649 | $0.2535 | 3,348,370 | 132,660 | 3.96% |
07-01-2024 | $0.28 | $0.265 | $0.28 | $0.2515 | 4,350,796 | 249,040 | 5.72% |
06-28-2024 | $0.29 | $0.271 | $0.29 | $0.2581 | 8,375,117 | 595,741 | 7.11% |
06-27-2024 | $0.264 | $0.2645 | $0.2739 | $0.2475 | 10,501,410 | 426,961 | 4.07% |
06-26-2024 | $0.2558 | $0.2642 | $0.2642 | $0.251 | 5,588,358 | 349,054 | 6.25% |
06-25-2024 | $0.2586 | $0.264 | $0.2655 | $0.25 | 5,705,950 | 206,008 | 3.61% |
06-24-2024 | $0.2656 | $0.264 | $0.2684 | $0.2515 | 6,478,415 | 258,406 | 3.99% |
06-21-2024 | $0.2665 | $0.264 | $0.2671 | $0.25 | 6,735,931 | 282,988 | 4.2% |
06-20-2024 | $0.27 | $0.2666 | $0.2715 | $0.26 | 5,073,147 | 101,549 | 2% |
06-18-2024 | $0.275 | $0.272 | $0.2763 | $0.2692 | 2,182,896 | 93,763 | 4.3% |
06-17-2024 | $0.2756 | $0.2718 | $0.278 | $0.268 | 4,256,983 | 160,076 | 3.76% |
06-14-2024 | $0.29 | $0.2892 | $0.29 | $0.275 | 5,496,888 | 36,604 | 0.67% |
06-13-2024 | $0.2972 | $0.29 | $0.2981 | $0.2804 | 3,144,164 | 38,571 | 1.23% |
06-12-2024 | $0.305 | $0.299 | $0.32 | $0.2897 | 4,799,236 | 189,054 | 3.94% |
06-11-2024 | $0.2795 | $0.3033 | $0.3122 | $0.279 | 6,243,970 | 229,419 | 3.67% |
06-10-2024 | $0.282 | $0.2839 | $0.2898 | $0.2711 | 4,992,591 | 30,126 | 0.6% |
06-07-2024 | $0.2815 | $0.2898 | $0.2898 | $0.27 | 6,844,119 | 91,398 | 1.34% |
06-06-2024 | $0.3005 | $0.2896 | $0.3005 | $0.27 | 12,179,814 | 230,765 | 1.89% |
06-05-2024 | $0.2963 | $0.3 | $0.3049 | $0.285 | 15,290,412 | 458,343 | 3% |
06-04-2024 | $0.3435 | $0.332 | $0.3462 | $0.33 | 2,733,697 | 21,191 | 0.78% |
News, Short Squeeze, Breakout and More Instantly...
Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options for mental-health disorders, is reporting its audited financial results for the fiscal year en...
- Received U.S. Food and Drug Administration (“FDA”) Breakthrough Therapy Designation (“BTD”) for CYB003, its proprietary deuterated psilocybin analog in development for the adjunctive treatment of Major Depressive Disorder (“MDD”) - - Clinical si...
Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation, psychedelic-based treatment options, will be spotlighted during an upcoming online fireside chat at the H.C. Wa...